Christopher M. Burns, PhD, NRAEMT
Associate Professor of Biomedical Science
Director for Case Based Learning
cburns@roseman.edu
(702) 802-2847

  • BSc in Microbiology and Immunology, McGill University
  • PhD in Molecular, Cellular, and Developmental Biology, Indiana University
  • Post-doctoral fellow in Clinical Biochemistry at the University of Oxford

Dr. Burns is a leader developing new medical schools and implementing curriculum change with experience from five universities over the last decade. His mission is to prepare students for professional careers by promoting life-long learning, and ensuring that clinical skills are based on underlying basic science knowledge. He serves as Treasurer for the Team-Based Learning Collaborative, committee chair for the International Association of Medical Science Educators, and mentors faculty in leadership and education certificate programs. He is also a healthcare provider delivering pre-hospital emergency care at special events, conferences, and festivals as an Advanced-EMT with a locally-owned EMS company.


Ronald R. Fiscus, BS, MS, PhD
Interim Associate Dean for Research
Professor of Biomedical Sciences
rfiscus@roseman.edu
(702) 802-2822

  • BS in Chemistry (minors in Math and Physics), Iowa State University
  • MS in Neurophysiology/Neurochemistry, Iowa State University
  • PhD in Molecular Physiology/Pharmacology, Iowa State University
  • Postdoctoral Fellow, UCSD School of Medicine
  • Postdoctoral Fellow, Stanford University School of Medicine

Dr. Fiscus has served as a faculty member in the Department of Physiology at Loyola University of Chicago, Stritch School of Medicine and University of Kentucky College of Medicine. The Fiscus Lab at Roseman University studies the Molecular Pathobiology & Molecular Pharmacology of neurological diseases (Alzheimer’s, Parkinson’s and Lewy Body Dementia), Type-1 & Type-2 diabetes, obesity and cancer, with the goal of developing new, advanced technologies for discovering novel biomarkers of these diseases and for developing new therapeutic agents for effective treatment.


Carolyn Glaubensklee, PhD
Associate Professor of Biomedical Sciences
cglaubensklee@roseman.edu
(702) 802-2886

  • BS in Biology/Chemistry, University of Southern Colorado
  • MS Biomedical Sciences, University of New Mexico School of Medicine
  • PhD Biomedical Sciences (Physiology), University of New Mexico School of Medicine
  • BSN, University of Southern Colorado
  • Post-doctoral Training, UCSF and UC Berkeley

Dr. Glaubensklee has aided with two medical school start-ups and was actively involved in curricular development. Her most current research interests are curricular innovation and medical education.


Thuc Timothy Le, PhD
Assistant Professor, Department of Biomedical Sciences
tle5@roseman.edu
(702) 802-2820
Website

  • BS, University of California, Berkeley
  • PhD, University of Chicago
  • Post-doc, Purdue University—Ruth L Kirschtein National Research Service Award

Dr. Le’s laboratory employs coherent anti-Stokes Raman scattering microscopy and nano-fluidic proteomics to study fatty liver disease and cancer. His research was previously funded by the National Heart, Lung, and Blood Institute, American Cancer Society, Nevada IDeA Network of Biomedical Research Excellence, Vons Breast Cancer Foundation, and the Department of Defense.


Aurelio Lorico, MD, PhD
Associate Professor of Biomedical Sciences and Co-Director, Cancer Research Program
alorico@roseman.edu
(702) 822-5395
Website

  • MD, Palermo University School of Medicine
  • PhD, Ferrara University School of Medicine
  • Post-doc, Yale University

Dr. Lorico did his post-doc at Yale University, mentored in the pharmacology field by Dr. Alan Sartorelli. There, he clarified the biological function(s) of the MRP1 (multidrug resistance protein 1) gene by generating and characterizing MRP1 knockout mice and cell lines. After 8 years at Yale, he became senior scientist at the Norwegian Cancer Center in Oslo, where he designed new strategies for gene therapy of hereditary diseases. Back in the United States, he has been working on the mechanisms of cancer metastases and on the development of innovative therapeutic strategies for breast cancer, melanoma and glioblastoma.

Current projects in Dr. Lorico’s lab focus on the study of extracellular vesicles, in particular exosomes: characterization, intracellular pathways and possible use as therapeutic targets and cancer biomarkers. Dr. Lorico’s lab has recently discovered “spathasomes”, subdomains of Rab7+ late endosomes and nuclear envelope invaginations that come together to create a sub-nuclear compartment, where biomaterials associated with exosomes are delivered. Current goals are to clarify the function of the spathasome pathway; to target this novel pathway in cancer cells and in cells of the tumor microenvironment; to utilize extracellular vesicles as diagnostic and prognostic biomarkers.


Ranjana Mitra, PhD
Assistant Professor
rmitra@roseman.edu
(702) 822-5194
Website

  • BS in Chemistry /Biology – University of Gorakhpur, India
  • MS in Molecular Biology and Biotechnology – G.B. Pant University, India
  • PhD in Molecular Biology – Jawaharlal Nehru University, India
  • Postdoctoral fellow – Breast and Lung cancer, Indiana University Purdue University Medical School
  • Research Instructor -Breast and Lung Cancer, University of Minnesota Medical School
  • Senior Scientist – Prostate and Breast Cancer, Nevada Cancer Institute

Her laboratory is focused on understanding the role of P450-CYP3A4/5 enzymes in regulating androgen receptor (AR) signaling in prostate cancer and tamoxifen resistant breast cancer. Her laboratory has identified a novel therapeutic approach, targeting the CYP3A5-HSP90 interphase regulating AR signaling, which can help improve the efficacy of androgen deprivation therapy in prostate cancer. She has also been involved in understanding the role of fatty acid signaling in circulating tumor cells which are important indicators of metastasis and associated with a poor prognosis.


Jaya Pamidimukkala, PhD
Associate Professor of Biomedical Sciences
jpamidimukkala@roseman.edu
702-802-2883

  • PhD in Pharmacology, University of Houston
  • Post-doctoral Training, University of Missouri-Columbia, Dalton Cardiovascular Research Center

Dr. Pamidimukkala’s research has been directed towards understanding the pathology underlying hypertension and the influence of factors such as sex hormones, obesity and inflammation.


Willis K. Paull PhD
Professor of Biomedical Sciences
Interim Chair, Biomedical Sciences
wpaull@roseman.edu
(702) 802-2857

  • BS and MS, Montana State University
  • PhD in Anatomy, from University of Southern California

Dr. Paull has been a faculty member in medical schools at the University of Vermont, Medical College of Georgia, Tulane University, University of Missouri-Columbia, Florida State University, Florida Atlantic University and Roseman University. He has served as department chairman on three occasions and also as vice dean for faculty affairs, research and graduate programs.   His research interests have been in the field of neuroendocrinology.


Germana Rappa, MD, PhD
Associate Professor of Biomedical Sciences and Co-Director, Cancer Research Program
grappa@roseman.edu
(702) 822-5173

  • MD, Milan University School of Medicine
  • PhD, Ferrara University

Dr. Rappa initially trained at the National Cancer Institute in Milan with Gianni Bonadonna and Massimo Gianni in the field of breast cancer. She worked for 8 years at the Department of Pharmacology and Cancer Center of Yale University and for 7 years at the Norwegian Cancer Center in Oslo. Her current interests are in the biology and therapy of breast cancer and melanoma metastases.


Rouel S. Roque, MD
Professor of Biomedical Sciences
rroque@roseman.edu
(702) 802-2862

  • MD, University of the Philippines
  • Post-doctoral Training, Medical College of Georgia

Dr. Roque earned the rank of Assistant Professor of Cell Biology and Genetics at the University of North Texas Health Science Center where he served as Assistant Departm ent Chair and Director of Gross Anatomy. Before joining Roseman, he was the Director of Anatomy and the Founding Director of the Medical Health Sciences Program at Touro University Nevada in Henderson, Nevada. Dr. Roque has been an active funded researcher for more than 30 years with expertise in Stem Cell Biology and Neuroscience.


Ken S. Rosenthal, PhD
Professor of Biomedical Sciences
Director of Microbiology and Immunology
Professor Emeritus, NE Ohio Medical University
krosenthal@roseman.edu
(702) 802-2855

  • BS in Chemistry, University of Deleware
  • MA and PhD in Biochemistry, University of Illinois
  • Post-doctoral Training, Dana Farber Cancer Institute and Harvard Medical School

Dr. Rosenthal has received funding from the N.I.H., the American Cancer Society, and the Pharmaceutical and Biotech Industry for the development and study of vaccines for viruses, cancer, and autoimmune diseases, immune-modulators, antibacterial and antiviral drugs, as well as mechanisms of pathogenesis of herpes simplex virus.


Stephanie Wragg, PhD
Assistant Dean, Curriculum and Assessment
Associate Professor, Biomedical Sciences
swragg@roseman.edu
(702) 802-2843

  • BS and MS in Microbiology and Immunology, McGill University, Montreal.
  • MS and PhD in Biochemistry, University of Rochester School of Medicine and Dentistry.
  • Post-doctoral Training, University of Oxford.

Dr. Wragg oversees the four-year educational program. Her portfolio includes curriculum development, student assessment and programmatic evaluation. Dr. Wragg directs the college’s accreditation process, based on her experience on numerous accreditation surveys of medical schools. Dr. Wragg has held faculty appointments in biochemistry and medicine.